A New Kind of Home Dialysis

Restricted access

Simergent announced plans to use a new round of seed money, $2.835 million, to further development of a cheaper, quieter home dialysis machine. The company, with offices in Oklahoma City and Chicago, said in a media release that its Archimedes dialysis system “aims to reduce healthcare expenditures, improve patient health, and make it easier for patients to perform dialysis at home.”

The majority of funding for this innovation comes from the Oklahoma-based company i2E. The funding will support Simergent as it continues to design the system, manufacture the device, and perform regulatory testing needed for FDA approval.

Website ChicagoInno.com

Save